Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...
Bli en del av Novartis, här kan du se mer om vilka karriärmöjligheter som finns.
Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical ...
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030 Enables manufacturing of medicines across company’s main therapeutic ...
Basel, November 20, 2025 – Novartis today rolled forward its mid-term guidance to 2025-2030 with a sales CAGR of +5-6% cc. The updated outlook will be featured at its Meet Novartis Management event in ...
ノバルティス ファーマ株式会社（本社：東京都港区、代表取締役社長：ジョンポール・プリシーノ、以下「ノバルティス ファーマ」）は、本日、眼科用血管内皮増殖因子（VEGF）阻害剤 ...
Explore opportunities with Novartis below.
Novartis heeft wereldwijd zowat 119.000 medewerkers waarvan er 2000 in België werken. Het aantrekken van getalenteerde mensen, hen ontwikkelen en behouden is van cruciaal belang voor ons. Daarmee ...
Asciminib (Scemblix®) nun auch zur Behandlung erwachsener Patient*innen mit neu diagnostizierter CML zugelassen1Zulassung basiert auf Ergebnissen der Phase-III ...
「がん」と「循環器疾患」は重大な健康課題と言えます。 プロジェクトTWFCは、これらの健康課題に対して、 自治体・企業・学校等が地域共創での予防啓発を行い、 持続可能な地域社会の ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback